Concepedia
Statistics
Publications
10
Citations
718
H-Index
Active since
2005
Affiliations
AstraZeneca (United Kingdom)(Current)
Loughborough University
Altimmune (United States)
Aimmune Therapeutics (United Kingdom)
AstraZeneca (Sweden)
Philip R. Mallinder is an author at AstraZeneca (United Kingdom) specializing in pharmacology, medicine, and molecular biology.
Publications per year
2005–2020
Anchored plasticity opens doors for selective inhibitor design in nitric oxide synthase
Elsa D. Garcin, A.S. Arvai, R.J. Rosenfeld et al. · Nature Chemical Biology · 2008 · 270 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +12
Late Intervention with a Myeloperoxidase Inhibitor Stops Progression of Experimental Chronic Obstructive Pulmonary Disease
Andrew Churg, Caroline Marshall, Don D. Sin et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 107 citations
Medicine, Immunology, Pharmacology +16
Identification of a Putative Intracellular Allosteric Antagonist Binding-Site in the CXC Chemokine Receptors 1 and 2
David Nicholls, Nick P. Tomkinson, Katherine Wiley et al. · Molecular Pharmacology · 2008 · 85 citations
Medicine, Molecular Biology, Pharmacology +17
Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors
Ani Sarkis Balmanoukian, Jeffrey R. Infante, Raid Aljumaily et al. · Clinical Cancer Research · 2020 · 55 citations · Full text
Medicine, Oncology, Pharmacology +7
A Novel Murine GITR Ligand Fusion Protein Induces Antitumor Activity as a Monotherapy That Is Further Enhanced in Combination with an OX40 Agonist
Rebecca Leyland, Amanda Watkins, Kathy Mulgrew et al. · Clinical Cancer Research · 2017 · 52 citations
Medicine, Oncology, Pharmacology +17
1–5 of 10